Inicio > Gastroenterología > Factores pronósticos asociados a la mortalidad de pacientes enfermos de Cirrosis Hepática > Página 13

Factores pronósticos asociados a la mortalidad de pacientes enfermos de Cirrosis Hepática

24. Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. Am J Gastroenterol. 2002; 97(11):2886-95.

25. MacKay IR. Autoimmune (lupoid) hepatitis. An entity in the spectrum of chronic active liver disease. J Gastroentrol Hepatol. 1990; 5:352-9.

26. Muratoti P, Czaja AJ, Muratori L. Genetic distinctions between autoimmune hepatitis in Italy and North America. World J Gastroenterol. 2005; 11:1862-6.

27. Manns MP, Strassburg CP. Autoimmune hepatitis: Clinical challenges. Gastroenterology. 2001; 120:1507-17.

28. Trapero-Marugán M, García-Buey L, Moreno-Otero R. Estrategia terapéutica en la hepatitis autoinmunitaria. Gastroenterol Hepatol. 2006; 29 (Supl 1):43-8.

29. Montano- Loza AJ, Carpenter HA, Czaja AJ. Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse. American Journal of Gastroenterology. 2007; 102:1005-12.

30. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med, 2005; 353:1261-1273.

31. Metcalf J and Oliver J. The geoepidemiology of primary biliary cirrosis. Seminars in Liver Disease. 1997; 17:13-22.

32. Selmi Carlo, Invernizzi Pietro, Zuin Massimo, Podda Mauro, and Gershwin M. Eric. Genetics and Geoepidemiology of Primary Biliary Cirrhosis: Following the Footprints to Disease Etiology. Seminars in Liver Disease. 2005; 25 (3):265-80.

33. Adam R, McMaster P, O’Grady JG, Castaing D, Klempnauer JL, Jamieson N. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl. 2003; 9:1231-43.

34. Martín-Llahí M, Guevara M, Ginès P. Nuevos tratamientos para la ascitis en la cirrosis hepática. Gastroenterol Hepatol. 2007; 30 (1):42-50.

35. Torre A, M. Martín-Llahí M, Ginès P. Hiponatremia dilucional, ascitis refractaria y síndrome hepatorrenal: tratamiento actual. Gastroenterol Hepatol. 2004; 27 (Supl 4):26-39.

36. Fernández-Esparrach G, Sanchez-Fueyo A, Ginés P, Uriz J, Quinto L, Ventura PJ, et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol. 2001; 34:46-52.

37. Garcia-Tsao G. Spontaneous bacterial peritonitis: a historical perspective.J Hepatol. 2004; 41:522-527.

38. Titó L, Rimola A, Ginés P, Llach J, Arroyo V, Rodes J. Recurrence of spontaneous bacterial peritonitis in cirrhosis. Frequency and predictive factors. Hepatology. 1988; 8:27-31.

39. Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology. 1994; 20:495-501.

40. Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol. 2003; 38:S69-S89.
41. Cárdenas A, Arroyo V. Fisiopatología y tratamiento de la ascitis y de los trastornos de la función renal en el

paciente cirrótico. En: Berenguer J editor. Gastroenterología y Hepatología. Tercera Edición, editora Elservier Science. Barcelona; 2002. p. 768-77.

42. Albillos A, Bosch J, García JC, Moitinho E, Ruiz L. Hipertensión Portal. En: Berenguer J editor. Gastroenterología y Hepatología. Tercera Edición, editora Elselvier Science. Barcelona; 2002. p. 745-55.

43. Bosch J, García-Pagan J. Prevention of variceal rebleeding. Lancet. 2003; 361:952-4.

44. Thabut D and Bernard-Chabert B. Management of acute bleeding from portal hypertension. Best Practice & Research Clinical Gastroenterology. 2007; 21(1):19- 29.

45. Carbonell N, Pauwels A, Serfaty L. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004; 40(3): 652-5.

46. Riggio O and Merli M. Prevention and treatment of hepatic encephalopathy. En: Arroyo V, Sánchez- Fueyo A, Fernández- Gómez J, Forns X, Ginés P, Rodés J editors. Advances in the Therapy of Liver Diseases. Editora Ars Medica. Barcelona, España; 2007: 61-69.

47. Wright G, Jalan R. Management of hepatic encephalopathy in patients with cirrhosis. Best Practice & Research Clinical Gastroenterology. 2007; 21(1):95-110.

48. García-Pagán JC, Calleja JL, Bañares R. Enfermedades hepáticas. Gastroenterol Hepatol. 2006; 29(Supl 3):99-111.

49. Bajaj JS, Saeian K, Verber MD, Hoffman RG, Rao SM. Inhibitory control test is a simple rapid and reliable test to detect minimal hepatic encephalopathy. Gastroenterology. 2006; 130 Suppl 2:A-760-62.

50. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, Rodés J. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol. 1999; 30(5):890-5.

51. Rodríguez-Roisin R and Krowka MJ. Hepatopulmonary syndrome–a liverinduced lung vascular disorder. N Engl J Med. 2008;358(22):2378-87.

52. Kamath P. Portopulmonary hypertension and hepatopulmonary syndrome. J Gastroenterol Hepatol. 2002; 17:S253-S5.

53. Capocaccia R, Sant M, Berrino F, Simonetti A, Santi V, Trevisani F. Hepatocellular Carcinoma: Trends of Incidence and Survival in Europe and the United States at the End of the 20th Century. Am J Gastroenterol. 2007; 102:1661–70.

54. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Heptol. 2006; 45:529-38.

55. Poniachik J, Bernstein DE, Reddy KR, Jeffers LJ, Coelho-Little ME, Civantos F, Schiff ER.The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc. 1996; 43(6):568-71.

56. Weickert U, Siegel E, Schilling D, Eickhoff A, Jakobs R, Bohrer MH, Riemann JF. The diagnosis of liver cirrhosis: a comparative evaluation of standard laparoscopy, mini-laparoscopy and histology. Z Gastroenterol. 2005 Jan; 43(1):17-21.

57. Gil Grande L. La biopsia hepática ciega en la medicina actual. Rev Clin Esp.2003; 203(5):219-20.

58. Denzer UW, Arnoldy A, Weickert U, Kanzler S, Galle PR, Riemann JR, et al. Prospective randomised comparison of mini-Laparoscopy and percutaneous liver biopsy. Analysis of 1000 examinations. Z Gastroenterol. 2005; 43-48.

59. Carrión JA, Colmenero J, Bataller R, Forns X. Diagnóstico no invasivo de la fibrosis hepática. Gastroenterol Hepatol. 2007; 30(Supl 1):106-12.

60. Heidelbaugh JJ, Bruderly M. Cirrhosis and Chronic Liver Failure: Part I. Diagnosis and Evauation. American Family Physician. 2006; 74( 5):556-62.

61. Fontaine H, Karine Petitprez K, Roudot-Thoraval F and Trinchet JC Guidelines for the diagnosis of uncomplicated cirrhosis. Gastroenterol Clin Biol. 2007; 31:504-509.

62. Giannini EG, Zaman A, Ceppa P, Mastracci L, Risso D, Testa R. A simple approach to noninvasively identifying significant fibrosis in chronic hepatitis C patients in clinical practice. J Clin Gastroenterol. 2006; 40 (6):521-7.

63. Poynard T, Bedossa P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups. J Viral Hepat. 1997; 4:199-208.